Abstract
Inherited deficiencies of the L-lysine catabolic pathway cause glutaric aciduria type I and pyridoxine-dependent epilepsy. Dietary modulation of cerebral L-lysine metabolism is thought to be an important therapeutic intervention for these diseases. To better understand cerebral L-lysine degradation, we studied in mice the two known catabolic routes — pipecolate and saccharopine pathways — using labeled stable L-lysine and brain peroxisomes purified according to a newly established protocol. Experiments with labeled stable L-lysine show that cerebral L-pipecolate is generated along two pathways: i) a minor proportion retrograde after ε-deamination of L-lysine along the saccharopine pathway, and ii) a major proportion anterograde after α-deamination of L-lysine along the pipecolate pathway. In line with these findings, we observed only little production of saccharopine in the murine brain. L-pipecolate oxidation was only detectable in brain peroxisomes, but L-pipecolate oxidase activity was low (7 ± 2μU/mg protein). In conclusion, L-pipecolate is a major degradation product from L-lysine in murine brain generated by α-deamination of this amino acid.
Similar content being viewed by others
Abbreviations
- α-AAA:
-
α-aminoadipate
- α-AASA:
-
α-aminoadipate semialdehyde
- AADAT:
-
α-aminoadipate aminotransferase
- AASDH:
-
α-aminoadipate semialdehyde dehydrogenase
- AASS:
-
α-aminoadipate semialdehyde synthase
- BBB:
-
blood brain barrier
- Clofibrate:
-
2-(4-chlorophenoxy)-2-methylpropionic acid ethyl ester
- D-AAO:
-
D-amino acid oxidase
- DHTKD1:
-
E1 subunit of an OGDHc-like complex
- GA:
-
glutaric acid
- GA-I:
-
glutaric aciduria type I
- GCDH:
-
glutaryl-CoA dehydrogenase
- GC/MS:
-
gas chromatography mass spectrometry
- HMP:
-
heavy mitochondrial pellet
- IF:
-
intermediate fraction of the cerebral sucrose gradient
- IF:
-
interphase of the liver density gradient
- i.p.:
-
intraperitoneal
- LC-MS/MS:
-
liquid chromatography tandem mass spectrometry
- LL:
-
lower layer of the cerebral sucrose gradient
- L-PIPOX:
-
L-pipecolate oxidase
- MPE:
-
molar percentage excess
- N:
-
nuclear pellet
- PBS:
-
phosphate-buffered saline
- PPARα:
-
peroxisome proliferator-activated receptor-alpha
- PMP-70:
-
peroxisomal membrane protein-70
- pPMS:
-
pooled post mitochondrial supernatant
- pPNS:
-
pooled post nuclear supernatant
- PYCR1:
-
pyrroline-5-carboxylate reductase
- P6C:
-
Δ1-piperideine-6-carboxylate
- SDS-PAGE:
-
sodium dodecyl sulfate polyacrylamide gel electrophoresis
- SF:
-
suspension fraction
- (s)LMP:
-
(suspended) light mitochondrial pellet of the liver
- (s)LMP 1 or 2:
-
(suspended) light mitochondrial pellet 1 or 2 of the brain
- TCA-cycle:
-
tricarboxylic acid-cycle
- UL:
-
upper layer of the cerebral sucrose gradient
- UQCRC2:
-
subunit of the bc 1 complex
- 3-OH-GA:
-
3-hydroxyglutaric acid
References
Blemings KP, Crenshaw TD, Swick RW, Benevenga NJ (1994) Lysine-alpha-ketoglutarate reductase and saccharopine dehydrogenase are located only in the mitochondrial matrix in rat liver. J Nutr 124:1215–1221
Chang YF (1976) Pipecolic acid pathway: the major lysine metabolic route in the rat brain. Biochem Biophys Res Commun 69:174–180
Cimini AM, Moreno S, Giorgi M, Serafini B, Cerú MP (1993) Purification of peroxisomal fraction from rat brain. Neurochem Int 23:249–260
Danhauser K, Sauer SW, Haack TB et al (2012) DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am J Hum Genet 91:1082–1087
Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria; a “new” disorder of amino acid metabolism. Biochem Med 12:12–21
Higashino K, Fujioka M, Yamamura Y (1971) The conversion of L-lysine to saccharopine and alpha-aminoadipate in mouse. Arch Biochem Biophys 142:606–614
Horie S, Ogawa S, Suga T (1989) Identity of acyl-CoA oxidase with glutaryl-CoA oxidase. Life Sci 44:1141–1148
Ijlst L, de Kromme I, Oostheim W, Wanders RJ (2000) Molecular cloning and expression of human L-pipecolate oxidase. Biochem Biophys Res Commun 270:1101–1105
Kok RM, Kaster L, de Jong AP, Poll-Thé B, Saudubray JM, Jakobs C (1987) Stable isotope dilution analysis of pipecolic acid in cerebrospinal fluid, plasma, urine, and amniotic fluid using electron capture negative ion mass fragmentography. Clin Chim Acta 168:143–152
Kovacs WJ, Faust PL, Keller GA, Krisans SK (2001) Purification of brain peroxisomes and localization of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Eur J Biochem 268:4850–4859
Lazarow PB, De Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A 73:2043–2046
Lazo O, Singh AK, Singh I (1991) Postnatal development and isolation of peroxisomes from brain. J Neurochem 56:1343–1353
Leighton F, Coloma L, Koenig C (1975) Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. J Cell Biol 67:281–309
Mihalik SJ, Rhead WJ (1989) L-pipecolic acid oxidation in the rabbit and cynomolgus monkey. Evidence for differing organellar locations and cofactor requirements in each species. J Biol Chem 264:2509–2517
Mihalik SJ, Rhead WJ (1991) Species variation in organellar location and activity of L-pipecolic acid oxidation in mammals. J Comp Physiol B 160:671–676
Mills PB, Struys E, Jakobs C et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307–309
Murthy SN, Janardanasarma MK (1999) Identification of L-amino acid/L-lysine alpha-amino oxidase in mouse brain. Mol Cell Biochem 197:13–23
Sacksteder KA, Biery BJ, Morrell JC et al (2000) Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. Am J Hum Genet 66:1736–1743
Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170
Singh H, Usher S, Poulos A (1989) Mitochondrial and peroxisomal beta-oxidation of stearic and lignoceric acids by rat brain. J Neurochem 53:1711–1718
Struys EA, Jakobs C (2010) Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation. FEBS Lett 584:181–186
Struys EA, Jansen EE, Salomons GS (2014) Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ1-piperideine-6-carboxylate generating L-pipecolic acid. J Inherit Metab Dis 37:327–332
Vamecq J, Van Hoof F (1984) Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. Biochem J 221:203–211
van Veldhoven PP, Vanhove G, Assselberghs S, Eyssen HJ, Mannaerts GP (1992) Substrate specificities of rat liver peroxisomal acyl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J Biol Chem 267:20065–20074
Völkl A, Fahimi HD (1985) Isolation and characterization of peroxisomes from the liver of normal untreated rats. Eur J Biochem 149:257–265
Wanders BJ, Denis SW, Dacremont G (1993) Studies on the substrate specificity of the inducible and non-inducible acyl-CoA oxidases from rat kidney peroxisomes. J Biochem 113:577–582
Zaar K, Angermüller S, Völkl A, Fahimi HD (1986) Pipecolic acid is oxidized by renal and hepatic peroxisomes. Implications for Zellweger’s cerebro-hepato-renal syndrome (CHRS). Exp Cell Res 164:267–271
Acknowledgments
We thank Christian Körner (Division of Inherited Metabolic Diseases, University Children’s Hospital, Heidelberg, Germany) for his kind gift of a primary antibody, Pamela M. Okun for her valuable comments on the manuscript (Center for Rare Diseases, Medical Center University of Heidelberg, Germany) and Kathrin V. Schmidt as well as Patrik Feyh (Metabolic Laboratory, University Children’s Hospital, Heidelberg, Germany) for their excellent technical assistance. We are grateful to Claus-Dieter Langhans (Metabolic Laboratory, University Children’s Hospital, Heidelberg, Germany) for critical discussion of our manuscript.
Conflict of interest
None.
Animal rights
All institutional and national guidelines for the care and use of laboratory animals were followed.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Robert Steiner
Sven W. Sauer and Jürgen G. Okun contributed equally to the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplemental Fig. 1
Fractionation protocol for the isolation of murine liver (a) and brain (b) peroxisomal subpopulations. For further description see materials and methods. N, nuclear pellet; pPNS, pooled post nuclear supernatant; HMP, heavy mitochondrial pellet; pPMS, pooled post mitochondrial supernatant; (s)LMP, (suspended) light mitochondrial pellet of the liver; IF + UL, intermediate fraction and upper layer of the cerebral sucrose gradient; Pellet + LL, pellet and lower layer of the cerebral sucrose gradient; SF, suspension fraction; LMP 1 or 2, light mitochondrial pellet 1 or 2 of the brain; sLMP 2, suspended LMP 2. Buffer A (5 mM MOPS, 0.25 M sucrose, 1 mM EDTA, 0.1 % (v/v) ethanol; pH 7.4); buffer B (5 mM MOPS, 0.85 M sucrose, 1 mM EDTA, 0.1 % (v/v) ethanol; pH 7.4); buffer C (5 mM MOPS, 1 mM EDTA, 0.1 % (v/v) ethanol; pH 7.4); buffer D (10 mM TRIS, 0.25 M sucrose, 1 mM EDTA, 0.1 % (v/v) ethanol; pH 7.4). (PPT 161 kb)
Supplemental Fig. 2
Distribution, purity and enrichment of liver (a) and brain (b) peroxisomes. Liver and brain gradient fractions were separated by SDS-PAGE, proteins blotted to nitrocellulose and investigated with antibodies against PMP-70, catalase, UQCRC2 and Golgi 58 K. Brain peroxisomes banded between fraction 2 to 4 and liver peroxisomes were nearly evenly distributed. The purest brain peroxisomal subpopulation is located in fraction 4, whereas mitochondria-depleted liver peroxisomal subpopulations mostly dispersed between fraction 5 to the interphase (PPTX 94 kb)
Rights and permissions
About this article
Cite this article
Posset, R., Opp, S., Struys, E.A. et al. Understanding cerebral L-lysine metabolism: the role of L-pipecolate metabolism in Gcdh-deficient mice as a model for glutaric aciduria type I. J Inherit Metab Dis 38, 265–272 (2015). https://doi.org/10.1007/s10545-014-9762-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-014-9762-z